Evolution of Multivalent Aptamer Corona for High‐Throughput Multiplexed Detection of Multiple Cancers
Advanced Science · 2026
DOI: 10.1002/advs.202514976 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Mengjie Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Department, Molecular Science and Biomedicine Laboratory (MBL), State Key Laboratory of Chemo/Bio-Sensing and Chemometrics, College of C…. Hauptthemen laut MEDLINE: SELEX Aptamer Technique, Aptamers, Nucleotide, Protein Corona, Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, "Pioneer" and "Leading Goose" R&D Program of Zhejiang.
Abstract (Originalsprache)
Clinical in vitro diagnosis is essential in early diagnosis and prognostic assessment, yet antibody‐based assays face limitations in multiplexity and scalability. To address the growing demand for modern molecular diagnostics, a multivalent aptamer corona platform for high‐throughput is introduced and multiplexed multi‐cancer diagnosis. With clinical serum samples, ovarian cancer‐, lung cancer‐, and colorectal cancer‐based aptamer coronas are obtained through several rounds of alternating positive and negative systematic evolution of ligands by exponential enrichment (SELEX). Leveraging a de novo ProteoFish‐SELEX strategy, which integrates nanoparticle‐protein corona technology, a multivalent aptamer corona is evolved. Proteomic profiling of protein coronas revealed cancer‐associated protein signatures, while aptomic profiling of aptamer coronas identified high‐affinity cancer‐specific aptamers. With these aptamers, high diagnostic accuracy is demonstrated in multiplexed multi‐cancer detection using clinical cohorts. Multivalent aptamer corona's outstanding diagnostic performance, multiplexed detection capability, and sequencing‐enabled high‐throughput potential position it as a promising versatile tool for novel biomarker discovery and a transformative advancement in precision oncology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Department, Molecular Science and Biomedicine Laboratory (MBL), State Key Laboratory of Chemo/Bio-Sensing and Chemometrics, College of Chemistry and Chemical Engineering, Aptamer Engineering Center of Hunan…
- Institute of Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, 310022, China.
- Institute of Cancer Centre and Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macau SAR, 999078, China.
- State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, Chi…
ORCID-Profile: Yuan Liu
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- "Pioneer" and "Leading Goose" R&D Program of Zhejiang
- Zhejiang Provincial Natural Science Foundation of China
- Hangzhou Key Research and Development Program
- National Key Research and Development Program of China
Zitieren
APA
Wang, M., Jin, B., Dai, X., Huang, H., Liu, Q., Zhu, J., Ju, H., Chen, Q., Song, Y., Tan, W., & Liu, Y. (2026). Evolution of Multivalent Aptamer Corona for High‐Throughput Multiplexed Detection of Multiple Cancers. Advanced Science. https://doi.org/10.1002/advs.202514976
Vancouver
Wang M, Jin B, Dai X, Huang H, Liu Q, Zhu J, et al. Evolution of Multivalent Aptamer Corona for High‐Throughput Multiplexed Detection of Multiple Cancers. Advanced Science. 2026. doi:10.1002/advs.202514976
BibTeX
@article{Wang2026,
author = {Wang, Mengjie and Jin, Baichuan and Dai, Xin and Huang, Haozhe and Liu, Qiqi and Zhu, Jianqing and Ju, Haixing and Chen, Qixun and Song, Yongmei and Tan, Weihong and Liu, Yuan},
title = {Evolution of Multivalent Aptamer Corona for High‐Throughput Multiplexed Detection of Multiple Cancers},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202514976}
}
EUVIMED